Bindinglaw

US · guidance

CMS Pub. 100-03, ch. 1, § 200.1

Nesiritide for Treatment of Heart Failure Patients (Effective March 2, 2006)

activein force · 2026-08-25 – presentas-observed

A. General

Nesiritide (Natrecor®) is Food and Drug Administration (FDA)-approved for the intravenous treatment of

patients with acutely decompensated congestive heart failure (CHF) who have dyspnea (shortness of breath)

at rest or with minimal activity. Nesiritide is not self-administered.

B. Nationally Covered Indications

N/A

C. Nationally Non-Covered Indications

Effective for dates of service on or after March 2, 2006, the Centers for Medicare & Medicaid Services has

determined that there is sufficient evidence to conclude that the use of Nesiritide for the treatment of CHF is

not reasonable and necessary for Medicare beneficiaries in any setting.

D. Other

Effective for dates of service on or after March 2, 2006, this determination applies only to the treatment of

CHF and does not change Medicare Administrative Contractor (MAC) discretion to cover other off-label

uses of Nesiritide or use consistent with the current FDA indication for intravenous treatment of patients

with acutely decompensated CHF who have dyspnea at rest or with minimal activity.

History

(Rev. 173, Issued: 09-04-14, Effective: Upon Implementation: of ICD-10, Implementation: Upon Implementation of ICD-10)

Provenance

Source
cms.gov
Retrieved
2026-08-25
Edition
iom-2026-08-25
Content hash
ec1a6e9845b2fe678a11c751250a8765b14638229d821003bac6745c499307e6
View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs

Bindinglaw

Point-in-time US law with the receipt attached. Source URL, retrieval time, content hash, and validity dates on every answer.

curl api.binding.law/v1/law/coverage

© 2026 binding.law · a Jubal, Inc. productAttorneys and firms never pay. Ever.
CMS Pub. 100-03, ch. 1, § 200.1 — Nesiritide for Trea… · binding.law